| JXSL1300031 | ABP 501 | adalimumab | Injection | Biological Products | Import Drug Application | 2013-05-08 | 安进生物技术咨询（上海）有限公司 | Amgen Biology Technology Consulting (Shanghai) Co Ltd | Certificate Issued | 2015-08-10 | view |
| JXSL1700043 | Adalimumab-atto单抗注射液 | adalimumab | Injection | Biological Products | Import Drug Application | 2017-08-02 | 安进生物技术咨询（上海）有限公司 | Amgen Biology Technology Consulting (Shanghai) Co Ltd | Certificate Issued | 2018-08-13 | view |
| CXSL1400139 | 重组抗人肿瘤坏死因子(TNFα)单抗注射液(阿达木单抗) | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-02-03 | 华兰基因工程有限公司 | Hualan Genetic Engineering Co Ltd | Certificate Issued | 2017-02-13 | view |
| CYSB2000169 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-07-04 | 百奥泰生物制药股份有限公司 | Bio-Thera Solutions Ltd | Certificate Issued | 2021-03-25 | view |
| CYSB2400050 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-02-29 | | Shanghai Henlius Biopharmaceutical Co Ltd | | | view |
| JYSZ1900039 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2019-07-08 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2019-11-27 | view |
| CYSB2200048 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| JYSB1700160 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2017-09-13 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2018-11-23 | view |
| JYSB1200310 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2012-12-27 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2015-07-27 | view |
| CYSB2000220 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2020-09-30 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-11-26 | view |
| CYSB2000030 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-02-29 | 海正生物制药有限公司 | Hisun Biopharmaceutical Co Ltd | Certificate Issued | 2020-05-15 | view |
| CYSB2200049 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-02-16 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| CXSS1800027 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2018-11-15 | 信达生物制药（苏州）有限公司 | Innovent Biologics (Suzhou) Co Ltd | Certificate Issued | 2020-09-08 | view |
| CXSL1500037 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2015-05-12 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2017-02-13 | view |
| CYSB2200090 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2022-03-21 | | | | | view |
| JYSB2000237 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2020-06-13 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2020-08-20 | view |
| CYSB2400023 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products(原2) | Supplementary Application | 2024-01-23 | | Hisun Biopharmaceutical Co Ltd | | | view |
| JYSB1900037 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2019-01-26 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2019-06-05 | view |
| JYSZ2100520 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | License Renew | 2021-06-10 | | | | | view |
| JYSB1700111 | 阿达木单抗注射液 | adalimumab | Injection | Biological Products | Supplementary Application | 2017-06-08 | AbbVie Ltd | Abbvie Ltd | Certificate Issued | 2017-09-13 | view |
